title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2",20220510T094515,https://markets.businessinsider.com/news/stocks/adct-awaits-cami-trial-data-cstl-boosts-revenue-outlook-annx-to-report-hd-trial-data-in-q2-1031440845,ESTA,0.065452,Neutral,0.015493
